Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625
This examiner grants 81% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17990134 | ORGANIC COMPOUND AND SENSOR AND SENSOR EMBEDDED DISPLAY PANEL AND ELECTRONIC DEVICE | Non-Final OA | Samsung Electronics Co., Ltd. |
| 18279903 | PROCESS FOR PREPARING A MELAMINE CONDENSATION PRODUCT | Non-Final OA | BASF SE |
| 19312779 | TREATMENT OF A SELECTIVE POPULATION OF PATIENTS HAVING DEMENTIA WITH LEWY BODIES | Final Rejection | EIP Pharma, LLC |
| 18526572 | 2,8-DIAZASPIRO[4.5]DECANE COMPOUNDS | Non-Final OA | Genentech, Inc. |
| 18503009 | DOSING REGIMEN OF KRAS G12C INHIBITOR | Non-Final OA | AMGEN INC. |
| 18554345 | GLP-1 RECEPTOR AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING SAME | Non-Final OA | LG CHEM, LTD. |
| 18418800 | TETRADENTATE PLATINUM AND PALLADIUM COMPLEX EMITTERS CONTAINING PHENYL-PYRAZOLE AND ITS ANALOGUES | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18393497 | EMITTERS BASED ON OCTAHEDRAL METAL COMPLEXES | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Non-Final OA | Mindset Pharma Inc. |
| 18412997 | CYCLOSILAZANE PRECURSORS AND RELATED METHODS | Non-Final OA | ENTEGRIS, INC. |
| 18558931 | ALKYLAMIDE SUBSTITUTED, ANNULATED IMIDAZOLES AND USE THEREOF AS INSECTICIDES | Non-Final OA | Bayer Aktiengesellschaft |
| 17919650 | TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES | Non-Final OA | CORNELL UNIVERSITY |
| 18740078 | QUINOLINE DERIVATIVES | Non-Final OA | Gilead Sciences, Inc. |
| 18264670 | THIENOPYRROLE COMPOUNDS | Final Rejection | Gilead Sciences, Inc. |
| 18635402 | INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) | Non-Final OA | MEDIC Life Sciences Inc. |
| 18550005 | Anti Viral Therapy | Non-Final OA | The Queen's University of Belfast |
| 18416590 | NOVEL SALTS OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS | Final Rejection | InventisBio Co., Ltd. |
| 18566227 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | Non-Final OA | NIHON NOHYAKU CO., LTD. |
| 18387694 | SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS AND THEIR APPLICATIONS | Non-Final OA | YINCHANG HUMANWELL PHARMACEUTICAL CO., LTD. |
| 18289697 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RON-MUTATION-ASSOCIATED BILIARY TRACT CANCER | Non-Final OA | WELLMARKER BIO CO., LTD. |
| 18381456 | PHENYL CYCLOHEXANONE DERIVATIVES AND METHODS OF MAKING AND USING THEM | Non-Final OA | SPIRIFY PHARMA INC. |
| 18554291 | THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION | Non-Final OA | FUJIFILM TOYAMA CHEMICAL CO., LTD. |
| 18284236 | Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto | Non-Final OA | Children's Healthcare of Atlanta, Inc. |
| 18036867 | PYRAZOLO DERIVATIVES AS HUMAN DIHYDROOROTATE DEHYDROGENASE (HDHODH) INHIBITORS FOR USE AS ANTIVIRALS | Non-Final OA | DRUG DISCOVERY AND CLINIC S.R.L. |
| 18250457 | PROCESS FOR PURIFYING NOROXYMORPHONE | Non-Final OA | RHODES TECHNOLOGIES |
| 17617037 | FLUORESCENT COMPLEXES COMPRISING TWO RHODAMINE DERIVATIVES AND A NUCLEIC ACID MOLECULE | Non-Final OA | UNIVERSITE DE STRASBOURG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy